Drug Type Small molecule drug |
Synonyms TQD3606 |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaerobic bacterial infection | Phase 1 | CN | 11 Dec 2023 | |
Gram-Negative Bacterial Infections | Phase 1 | CN | 11 Dec 2023 | |
Gram-Positive Bacterial Infections | Phase 1 | CN | 11 Dec 2023 | |
Carbapenem Resistant Bacterial Infection | Phase 1 | CN | 04 Nov 2021 |